VMI

VHCP Management II Portfolio holdings

AUM $379M
This Quarter Return
+255.91%
1 Year Return
+424.39%
3 Year Return
+2,335.22%
5 Year Return
–
10 Year Return
–
AUM
$379M
AUM Growth
+$379M
Cap. Flow
-$40.7M
Cap. Flow %
-10.72%
Top 10 Hldgs %
94.12%
Holding
29
New
8
Increased
1
Reduced
7
Closed
9

Top Buys

1
CNST
Constellation Pharmaceuticals, Inc.
CNST
$36.5M
2
ISEE
IVERIC bio, Inc. Common Stock
ISEE
$8.62M
3
MRSN icon
Mersana Therapeutics
MRSN
$5.29M
4
RLMD icon
Relmada Therapeutics
RLMD
$4.48M
5
ADVM icon
Adverum Biotechnologies
ADVM
$4.42M

Top Sells

1
ASND icon
Ascendis Pharma
ASND
$22.6M
2
RARX
Ra Pharmaceuticals, Inc. Common Stock
RARX
$16M
3
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
$15.7M
4
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$13.6M
5
AXSM icon
Axsome Therapeutics
AXSM
$11.1M

Sector Composition

1 Healthcare 99.09%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
TXG icon
1
10x Genomics
TXG
$1.74B
$136M 35.91%
1,786,431
– –
AXSM icon
2
Axsome Therapeutics
AXSM
$6.05B
$81.2M 21.42%
785,981
-106,965
-12% -$11.1M
CNST
3
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$70.7M 18.64%
1,500,631
+773,954
+107% +$36.5M
BHVN
4
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$25.2M 6.64%
462,903
-250,000
-35% -$13.6M
SWAV
5
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$12.7M 3.34%
288,838
-357,589
-55% -$15.7M
ISEE
6
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$8.62M 2.27%
+1,004,299
New +$8.62M
KALV icon
7
KalVista Pharmaceuticals
KALV
$678M
$6.52M 1.72%
366,268
-10,621
-3% -$189K
OBSV
8
DELISTED
ObsEva SA Ordinary Shares
OBSV
$6.01M 1.58%
1,573,639
-678,821
-30% -$2.59M
MRSN icon
9
Mersana Therapeutics
MRSN
$36.5M
$5.29M 1.39%
+922,514
New +$5.29M
SPRO icon
10
Spero Therapeutics
SPRO
$116M
$4.56M 1.2%
474,015
– –
RLMD icon
11
Relmada Therapeutics
RLMD
$37.2M
$4.48M 1.18%
+114,876
New +$4.48M
ADVM icon
12
Adverum Biotechnologies
ADVM
$64.6M
$4.42M 1.16%
+383,620
New +$4.42M
MRNS
13
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$3.21M 0.85%
1,486,676
– –
FTSV
14
DELISTED
Forty Seven, Inc. Common Stock
FTSV
$3.06M 0.81%
+77,714
New +$3.06M
MIST icon
15
Milestone Pharmaceuticals
MIST
$156M
$2.38M 0.63%
148,560
– –
NXTC icon
16
NextCure
NXTC
$13.5M
$2.04M 0.54%
+36,249
New +$2.04M
MYOV
17
DELISTED
Myovant Sciences Ltd.
MYOV
$1.19M 0.31%
+76,768
New +$1.19M
ETNB icon
18
89bio
ETNB
$1.34B
$1.08M 0.29%
+41,235
New +$1.08M
BLPH
19
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
$230K 0.06%
659,087
-3,490,291
-84% -$1.22M
PTGX icon
20
Protagonist Therapeutics
PTGX
$3.67B
$227K 0.06%
32,211
-394,570
-92% -$2.78M
ASND icon
21
Ascendis Pharma
ASND
$11.8B
– –
-234,591
Closed -$22.6M
BCRX icon
22
BioCryst Pharmaceuticals
BCRX
$1.74B
– –
-2,874,602
Closed -$8.24M
KNSA icon
23
Kiniksa Pharmaceuticals
KNSA
$2.48B
– –
-540,461
Closed -$4.6M
KA
24
DELISTED
Kineta, Inc. Common Stock
KA
– –
-130,733
Closed -$110K
TCDA
25
DELISTED
Tricida, Inc. Common Stock
TCDA
– –
-118,886
Closed -$3.67M
1
2